GlassScriptPhysician profile
Scott J Zuick
NPI 1609800176
$33,033.23
in general payments reported to CMS, 2019-2025
53 companies · $3,959 in 2025
The $3,959 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,482 · 2020: $2,202 · 2021: $2,874 · 2022: $3,447 · 2023: $14K · 2024: $3,782 · 2025: $3,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $9,703 · Travel and Lodging: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,325.76 |
| Education | $9,702.82 |
| Travel and Lodging | $999.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,871.11 | 2022-2025 | Da Vinci Surgical System, Ion |
| Astrazeneca Pharmaceuticals LP | $4,056.53 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $3,624.16 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Genzyme Corporation | $1,994.47 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,442.24 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,347.66 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Grifols USA, LLC | $1,011.96 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $825.66 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Mylan Specialty L.P. | $630.19 | 2019-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $582.73 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $533.57 | 2019-2024 | |
| United Therapeutics Corporation | $479.65 | 2019-2024 | Tyvaso |
| Philips North America LLC | $394.24 | 2019-2025 | Encore, Vest Therapy Und, (8874) Incourage |
| Takeda Pharmaceuticals U.S.A., INC. | $391.81 | 2020-2025 | Glassia |
| Ethicon INC. | $367.36 | 2020-2022 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $331.64 | 2019-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $327.46 | 2021-2025 | Zerbaxa, Recarbrio, Winrevair |
| Insmed, INC. | $293.73 | 2019-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $292.42 | 2021-2025 | |
| Genentech USA, INC. | $269.38 | 2019-2025 | Xolair |
| Electromed, INC. | $260.29 | 2019-2024 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $256.09 | 2019-2024 | |
| Pfizer INC. | $178.01 | 2019-2025 | |
| Axsome Therapeutics, INC. | $136.66 | 2023-2025 | Sunosi |
| Gilead Sciences, INC. | $132.33 | 2021 | |
| Itamar Medical INC | $107.01 | 2024 | Watchpatone |
| Covidien LP | $84.31 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $74.53 | 2019-2023 | |
| Fisher & Paykel Healthcare INC | $64.04 | 2021-2025 | Fisher & Paykel Healthcare |
| Vifor Pharma, INC. | $47.45 | 2024-2025 | Zemaira, Veltassa |
| Baxter Healthcare | $47.05 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Abbvie INC. | $43.60 | 2023-2024 | Teflaro |
| Sanofi-Aventis U.S. LLC | $39.98 | 2020-2021 | |
| Verona Pharma, INC. | $38.97 | 2025 | Ohtuvayre |
| Shire North American Group INC | $34.49 | 2019 | |
| Advanced Respiratory, INC | $34.01 | 2019 | |
| Apria Healthcare LLC | $33.78 | 2021 | |
| Galvanize Therapeutics, INC | $33.05 | 2025 | Aliya System |
| Vanda Pharmaceuticals INC. | $30.47 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $29.67 | 2020-2024 | Eliquis |
| Cumberland Pharmaceuticals, INC. | $29.40 | 2021-2024 | Vibativ |
| Avadel Cns Pharmaceuticals, LLC | $28.46 | 2025 | Lumryz |
| Ani Pharmaceuticals, INC. | $22.73 | 2025 | Purified Cortrophin Gel |
| Lilly USA, LLC | $21.49 | 2025 | Zepbound |
| Resmed Corp | $21.33 | 2023 | |
| Daiichi Sankyo INC. | $20.73 | 2021 | |
| Biogen, INC. | $19.77 | 2023 | Spinraza |
| Paratek Pharmaceuticals, INC. | $18.94 | 2019 | |
| Veran Medical Technologies, INC. | $18.47 | 2021 | |
| Phadia US INC. | $16.69 | 2023 | Immunocap |
| Janssen Pharmaceuticals, INC | $14.64 | 2021 | |
| Pulmonx Corporation | $13.71 | 2022 | |
| Merit Medical Systems INC | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Zuick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.